Pulmonary vein dose and risk of atrial fibrillation in patients with non-small cell lung cancer following definitive radiotherapy: An NI-HEART analysis-Reference-Cited by-同舟云学术

Pulmonary vein dose and risk of atrial fibrillation in patients with non-small cell lung cancer following definitive radiotherapy: An NI-HEART analysis

Published:2024-03 Issue: Volume:192 Page:110085
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Walls Gerard M.^ORCID,McCann Conor,O'Connor John,O'Sullivan Anna,I. Johnston David,McAleese Jonathan,McGarry Conor K.,Cole Aidan J.,Jain Suneil,Butterworth Karl T.,Hanna Gerard G.

Publisher

Elsevier BV

Reference37 articles.

1. Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer;Spigel;Journal of Clinical Oncology,2022

2. Hui R, Özgüroğlu M, Villegas A, Daniel D, Vicente D, Murakami S, et al. Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study. Lancet Oncol [Internet]. 2019 Dec 1 [cited 2023 Sep 20]. 20(12). 1670–80. Available from: https://pubmed.ncbi.nlm.nih.gov/31601496/.

3. Bucknell NW, Belderbos J, Palma DA, Iyengar P, Samson P, Chua K, et al. Avoiding Toxicity With Lung Radiation Therapy: An IASLC Perspective. J Thorac Oncol [Internet]. 2022 Aug 1 [cited 2022 Oct 29]. 17(8). 961–7. Available from: https://pubmed.ncbi.nlm.nih.gov/35649502/.

4. Vivekanandan S, Landau DB, Counsell N, Warren DR, Khwanda A, Rosen SD, et al. The Impact of Cardiac Radiation Dosimetry on Survival After Radiation Therapy for Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys [Internet]. 2017 Sep 1 [cited 2022 Dec 5];99(1):51–60. Available from: http://www.redjournal.org/article/S0360301617308301/fulltext.

5. Chen L, Ta S, Wu W, Wang C, Zhang Q. Prognostic and Added Value of Echocardiographic Strain for Prediction of Adverse Outcomes in Patients with Locally Advanced Non-Small Cell Lung Cancer after Radiotherapy. Ultrasound Med Biol [Internet]. 2019 Jan 1 [cited 2022 Dec 9];45(1):98–107. Available from: https://pubmed.ncbi.nlm.nih.gov/30366608/.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening and risk analysis of atrial fibrillation after radiotherapy for breast cancer: Rationale and design for the Watch Your HeaRT cohort study (WATCH);2024-09-03

2. Moving beyond mean heart dose: The importance of cardiac substructures in radiation therapy toxicity;Journal of Medical Imaging and Radiation Oncology;2024-09-03

3. Optimizing Cardiovascular Risk Prediction From CT Imaging at the Radiation Oncology Point of Care;JACC: CardioOncology;2024-08

4. Association of Cardiac Substructure Radiation Dose With Arrhythmia;JACC: CardioOncology;2024-08

5. Cardiac Substructure Radiation Dose and Associations With Tachyarrhythmia and Bradyarrhythmia After Lung Cancer Radiotherapy;JACC: CardioOncology;2024-08